• 1667 Citations
  • 18 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maria Gomes da Silva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output at NOVA

  • 1667 Citations
  • 18 h-Index
  • 10 Article
  • 1 Letter

Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysis

Vidal, L., Gafter-Gvili, A., Salles, G., Bousseta, S., Oberman, B., Rubin, C., van Oers, M. H. J., Fortpied, C., Ghielmini, M., Pettengell, R., Witzens-Harig, M., Dreger, P., Vitolo, U., Silva, M. G. D., Evangelista, A., Li, H., Freedman, L., Habermann, T. M. & Shpilberg, O., May 2017, In : European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). p. 216-225 10 p.

Research output: Contribution to journalArticle

  • 27 Citations (Scopus)

    Delta one T cells for immunotherapy of chronic lymphocytic leukemia: Clinical-grade expansion/differentiation and preclinical proof of concept

    Almeida, A. R., Correia, D. V., Fernandes-Platzgummer, A., Da Silva, C. L., Silva, M. G. D., Anjos, D. R. & Silva-Santos, B., 2016, In : Clinical Cancer Research. 22, 23, p. 5795-5804 10 p.

    Research output: Contribution to journalArticle

  • 38 Citations (Scopus)

    KIR genotypic diversity in Portuguese and analysis of KIR gene allocation after allogeneic hematopoietic stem cell transplantation

    Ligeiro, D., Buhler, S., Abecasis, M., Abade, O., Sanchez-Mazas, A., Silva, M. G. D. & Trindade, H., May 2016, In : HLA. 87, 5, p. 375-380 6 p.

    Research output: Contribution to journalArticle

  • Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia

    Lúcio, P. & Silva, M. G. D., Jan 2014, In : Leukemia. 28, 1, p. 179-182

    Research output: Contribution to journalLetter

    50 Citations (Scopus)

    Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specific cell-permeable peptide inhibitor

    Martins, L. R., Perera, Y., Lúcio, P., Silva, M. G., Perea, S. E. & Barata, J. T., 2014, In : Oncotarget. 5, 1, p. 258-263 6 p.

    Research output: Contribution to journalArticle

    Open Access
  • 27 Citations (Scopus)
    2 Downloads (Pure)